Top News
Earlier Cabazitaxel Use in mCRPC Possibly Beneficial
Higher Risk of Ovarian Clear Cell Cancer in Asian Pacific Islanders
Intermittent Enzalutamide Dosing for mCRPC Probed
Prostate Cancer Death Risk Not Linked to 5-ARIs
Modest Survival Gains Reported in Newly Diagnosed Metastatic PCa
Cabazitaxel Linked to Better Pain Reduction in mCRPC
Longer Survival Seen With Sipuleucel-T Use in mCRPC
Strontium89 Now Available for Relief of Metastatic Bone Pain
Bariatric Surgery May Cut Risk for Colorectal Cancer in Obese Patients
EDITORIAL ADVISORY BOARD
E. David Crawford, MD
Jeffrey M. Farma, MD
Featured
-
2020 Genitourinary Cancers Symposium Coverage
News coverage from the 2020 Genitourinary Cancers Symposium in San Francisco, CA. -
Integrative Oncology: Using Evidence-Informed Medicine to Improve Patient Outcomes and Quality of Life
Lifestyle-based integrative treatment approaches — deemed scientifically sound by the field’s proponents — merge conventional and complementary treatments. -
An Early Study Suggests the Flu Shot Could Someday Be Used as Part of an Immunotherapy Regimen in Cancer
A new study describes how the flu vaccine creates an antitumoral response in mouse models of metastatic melanoma that has spread to the lungs. -
Risky Business: A New Scoring System for Metastatic Renal Cell Carcinoma
The new risk score, developed by Emory researchers, could be a useful tool for determining overall and progression-free survival after immunotherapy. -
Patient-Reported Outcomes That May Affect Treatment Decisions in Prostate Cancer
Validated PROMs can assist in providing high-quality care and improve a patient’s overall experience. -
Oral Oncology Parity Laws Don’t Make Medications More Affordable
Out-of-pocket spending remains high for many patients with blood cancers who are receiving tyrosine kinase inhibitors and immunomodulatory drugs.
More Features
Current and Prospective Treatment Options for Waldenström Macroglobulinemia
Researchers discussed diagnostic considerations, indications for therapy, and treatment options for patients with Waldenström macroglobulinemia.
Conference Organizers Can Help Oncologists Distill Practice-Changing Data
A SABCS 2019 session encouraged oncologists to scrutinize whether presentations are practice changing, and included a look at controversial data from KEYNOTE-522.
Patients With Cancer Who Vape Are at Significant Risk for EVALI
A nationwide outbreak of EVALI reports has highlighted the unknowns about one of the most popular forms of inhalation drug use in the US.
The Unexpected Costs of Cancer Treatment: Out-of-Network Billing
The cancer field is not immune to the challenges of out-of-network and surprise billing.
PAK4 in Melanoma: Could This Target Extend Immunotherapy’s Reach?
Combining PD-1 blockade with PAK4 inhibitors could boost the number of patients helped by the therapy.
Fact Sheets
Cosmetics or Personal Care Products and Cancer
